Circulating microparticles and thrombin generation in patients with Chronic Lymphocytic Leukemia

Detalhes bibliográficos
Autor(a) principal: Gontijo Evangelista, Fernanda Cristina
Data de Publicação: 2022
Outros Autores: Ferrão, Aline Lúcia Menezes, Duarte, Rita Carolina Figueiredo, Gomes, Lorena Caixeta, Alves, Luan Carlos Vieira, Nunes, Fernanda Freire, Braga, Tatiane Vieira, Santiago, Marie Gabriele, Silva Araújo, Sergio Schusterschitz da, Carvalho, Maria das Graças, Sabino, Adriano
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Pharmaceutical Sciences
Texto Completo: https://www.revistas.usp.br/bjps/article/view/204998
Resumo: Chronic Lymphocytic Leukemia (CLL) has shown great biological heterogeneity, with a variable prognosis, and a short survival in some patients. In this light, the present study focused on the prognostic utility of circulating microparticles (MPs) and a Thrombin Generation (TG) Profile for thrombotic risk and disease progression in CLL patients. Circulating microparticles and TG were evaluated in 35 patients with CLL and 35 healthy individuals. For circulating microparticles, significant differences were observed among the following groups: MPs derived from endothelial cells (p = 0.002), B lymphocytes (p < 0.001), platelets (p = 0.003), and Tissue Factor MPs in monocytes (p < 0.001). In all cases, MP values were higher for the CLL group. When compared to the controls, CLL patients presented a decrease in TG, characterized by a reduced endogen thrombin potential (ETP) (p = 0.031). When the results were analyzed according to the Binet stage, as compared to the controls, the Binet B+C group also presented lower ETP values (p = 0.009). No significant differences were observed between the control and the Binet A groups or between the Binet A and the Binet B + C groups. Although hemostatic alterations may occur in patients with CLL, these parameters do not seem to be useful to indicate disease progression.
id USP-31_537ff778f7d8bef75f45855bc2e5aae0
oai_identifier_str oai:revistas.usp.br:article/204998
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
repository_id_str
spelling Circulating microparticles and thrombin generation in patients with Chronic Lymphocytic LeukemiaChronic lymphocytic leukemia PrognosisMicroparticlesThrombin GenerationChronic Lymphocytic Leukemia (CLL) has shown great biological heterogeneity, with a variable prognosis, and a short survival in some patients. In this light, the present study focused on the prognostic utility of circulating microparticles (MPs) and a Thrombin Generation (TG) Profile for thrombotic risk and disease progression in CLL patients. Circulating microparticles and TG were evaluated in 35 patients with CLL and 35 healthy individuals. For circulating microparticles, significant differences were observed among the following groups: MPs derived from endothelial cells (p = 0.002), B lymphocytes (p < 0.001), platelets (p = 0.003), and Tissue Factor MPs in monocytes (p < 0.001). In all cases, MP values were higher for the CLL group. When compared to the controls, CLL patients presented a decrease in TG, characterized by a reduced endogen thrombin potential (ETP) (p = 0.031). When the results were analyzed according to the Binet stage, as compared to the controls, the Binet B+C group also presented lower ETP values (p = 0.009). No significant differences were observed between the control and the Binet A groups or between the Binet A and the Binet B + C groups. Although hemostatic alterations may occur in patients with CLL, these parameters do not seem to be useful to indicate disease progression.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2022-12-19info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/20499810.1590/s2175-97902022e19407 Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)Brazilian Journal of Pharmaceutical Sciences; v. 58 (2022)Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)2175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/204998/194506Copyright (c) 2022 Brazilian Journal of Pharmaceutical Scienceshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessGontijo Evangelista, Fernanda Cristina Ferrão, Aline Lúcia MenezesDuarte, Rita Carolina FigueiredoGomes, Lorena CaixetaAlves, Luan Carlos Vieira Nunes, Fernanda FreireBraga, Tatiane VieiraSantiago, Marie Gabriele Silva Araújo, Sergio Schusterschitz daCarvalho, Maria das GraçasSabino, Adriano2023-04-10T19:14:04Zoai:revistas.usp.br:article/204998Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2023-04-10T19:14:04Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Circulating microparticles and thrombin generation in patients with Chronic Lymphocytic Leukemia
title Circulating microparticles and thrombin generation in patients with Chronic Lymphocytic Leukemia
spellingShingle Circulating microparticles and thrombin generation in patients with Chronic Lymphocytic Leukemia
Gontijo Evangelista, Fernanda Cristina
Chronic lymphocytic leukemia
Prognosis
Microparticles
Thrombin Generation
title_short Circulating microparticles and thrombin generation in patients with Chronic Lymphocytic Leukemia
title_full Circulating microparticles and thrombin generation in patients with Chronic Lymphocytic Leukemia
title_fullStr Circulating microparticles and thrombin generation in patients with Chronic Lymphocytic Leukemia
title_full_unstemmed Circulating microparticles and thrombin generation in patients with Chronic Lymphocytic Leukemia
title_sort Circulating microparticles and thrombin generation in patients with Chronic Lymphocytic Leukemia
author Gontijo Evangelista, Fernanda Cristina
author_facet Gontijo Evangelista, Fernanda Cristina
Ferrão, Aline Lúcia Menezes
Duarte, Rita Carolina Figueiredo
Gomes, Lorena Caixeta
Alves, Luan Carlos Vieira
Nunes, Fernanda Freire
Braga, Tatiane Vieira
Santiago, Marie Gabriele
Silva Araújo, Sergio Schusterschitz da
Carvalho, Maria das Graças
Sabino, Adriano
author_role author
author2 Ferrão, Aline Lúcia Menezes
Duarte, Rita Carolina Figueiredo
Gomes, Lorena Caixeta
Alves, Luan Carlos Vieira
Nunes, Fernanda Freire
Braga, Tatiane Vieira
Santiago, Marie Gabriele
Silva Araújo, Sergio Schusterschitz da
Carvalho, Maria das Graças
Sabino, Adriano
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Gontijo Evangelista, Fernanda Cristina
Ferrão, Aline Lúcia Menezes
Duarte, Rita Carolina Figueiredo
Gomes, Lorena Caixeta
Alves, Luan Carlos Vieira
Nunes, Fernanda Freire
Braga, Tatiane Vieira
Santiago, Marie Gabriele
Silva Araújo, Sergio Schusterschitz da
Carvalho, Maria das Graças
Sabino, Adriano
dc.subject.por.fl_str_mv Chronic lymphocytic leukemia
Prognosis
Microparticles
Thrombin Generation
topic Chronic lymphocytic leukemia
Prognosis
Microparticles
Thrombin Generation
description Chronic Lymphocytic Leukemia (CLL) has shown great biological heterogeneity, with a variable prognosis, and a short survival in some patients. In this light, the present study focused on the prognostic utility of circulating microparticles (MPs) and a Thrombin Generation (TG) Profile for thrombotic risk and disease progression in CLL patients. Circulating microparticles and TG were evaluated in 35 patients with CLL and 35 healthy individuals. For circulating microparticles, significant differences were observed among the following groups: MPs derived from endothelial cells (p = 0.002), B lymphocytes (p < 0.001), platelets (p = 0.003), and Tissue Factor MPs in monocytes (p < 0.001). In all cases, MP values were higher for the CLL group. When compared to the controls, CLL patients presented a decrease in TG, characterized by a reduced endogen thrombin potential (ETP) (p = 0.031). When the results were analyzed according to the Binet stage, as compared to the controls, the Binet B+C group also presented lower ETP values (p = 0.009). No significant differences were observed between the control and the Binet A groups or between the Binet A and the Binet B + C groups. Although hemostatic alterations may occur in patients with CLL, these parameters do not seem to be useful to indicate disease progression.
publishDate 2022
dc.date.none.fl_str_mv 2022-12-19
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/204998
10.1590/s2175-97902022e19407
url https://www.revistas.usp.br/bjps/article/view/204998
identifier_str_mv 10.1590/s2175-97902022e19407
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/204998/194506
dc.rights.driver.fl_str_mv Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)
Brazilian Journal of Pharmaceutical Sciences; v. 58 (2022)
Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1787713373885956096